A detailed history of Principal Financial Group Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 7,320 shares of HROW stock, worth $285,553. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,320
Holding current value
$285,553
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$20.85 - $46.47 $152,622 - $340,160
7,320 New
7,320 $329,000
Q2 2022

Aug 10, 2022

SELL
$5.75 - $7.74 $60,196 - $81,030
-10,469 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$6.77 - $8.66 $35,501 - $45,413
-5,244 Reduced 33.37%
10,469 $71,000
Q4 2021

Feb 09, 2022

BUY
$8.5 - $12.0 $133,560 - $188,556
15,713 New
15,713 $136,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.06B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.